European Journal of Cancer and Clinical Oncology
Volume 27, Issue 12, December 1991, Pages 1639-1642
PaperResistance modification by PSC-833, a novel non-immunosuppressive cyclosporin A
References (21)
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays
J Immunol Meth
(1983)- et al.
Restoration of daunomycin retention in multidrug resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative
Exp Cell Res
(1991) - et al.
Drug resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy
J Clin Oncol
(1989) - et al.
P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil
J Clin Oncol
(1991) - et al.
A pilot study of quinidine and epirubicin in the treatment of advanced breast cancer
Br J Cancer
(1990) - et al.
Reversal of drug-resistance by cyclosporin-A in a patient with acute myelocytic leukaemia
Br J Haematol
(1990) - et al.
Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphocytic leukaemia in vitro
J Clin Invest
(1986) - et al.
Competitive inhibition by verapamil for ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug resistance K562 cells without calcium ion involvement
Cancer Res
(1989) - et al.
Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multidrug resistant human lung cancer cell line
Br J Cancer
(1987) Modification of cytotoxic drug resistance by non-immunosuppressive cyclosporins
Br J Cancer
(1988)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1991 Published by Elsevier Ltd.